Psilocybin therapeutic use program establishment

SF 3971 establishes a regulated program in Minnesota for the therapeutic use of psilocybin by adults aged 21+ with qualifying medical conditions. The bill creates specific roles including registered patients, designated cultivators, and registered facilitators who oversee preparation, administration, and integration sessions. It outlines protections for participants, requires commissioner oversight, sets fees, and establishes an advisory committee, drawing on Minnesota's medical cannabis program model to prioritize patient safety and compassionate access. The program prohibits commercial sales and restricts use to therapeutic settings, not recreational purposes.